While pulmonary hypertension (PH) is a relatively rare problem in pediatrics, the frequency of the diagnosis and PH-related hospitalizations are rising.
Monthly Archive: April 2015
Researchers from The Children’s Hospital of Philadelphia’s PolicyLab recently published the largest study to date documenting the significant diabetes risk to children with a prescription for antipsychotics.
The most common complication for children who undergo CHD surgery in infancy is neurodevelopmental disability.
Scientists at The Children’s Hospital of Philadelphia are comparing two molecular therapy techniques for Dystonia — RNA interference (RNAi) and antisense oligonucleotides (ASOs).
Two undergraduate engineers from the Center for Injury Research and Prevention (CIRP) were recently honored during CHOP Research Poster Day.
Using gene therapy to produce a mutant human protein with unusually high blood-clotting power, scientists have successfully treated animals with the bleeding disorder hemophilia.
By using existing human drugs to improve metabolism and restore shortened lifespans in microscopic worms, scientists have set the stage for human clinical trials of possible innovative therapies for mitochondrial disease.
Stephen Hunger, MD and a team of researchers used highly sensitive deep sequencing techniques to see how genetic changes in acute lymphoblastic leukemia cells evolve from diagnosis to remission and relapse.
Severe pediatric sepsis is a challenge for critical care specialists who unfortunately see children in pediatric intensive care units die from body-wide inflammation and subsequent organ damage.
Investigators may be taken aback by the results of a simulation study published in the journal Research Policy by T. Eugene Day, D.Sc., of the Office of Safety and Medical Operations at The Children’s Hospital of Philadelphia, assessing how much bias is needed before grant funding decisions are swayed.